-
Pharmaceutical News of the Week (July. 6th-July. 10th) | PharmaSources.com - Updates on Approvals
PharmaSources/Caicai
July 21, 2020
With the second week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week.The news involved 6 sections: approval, R&D, policies, transactions, listing and miscellany that happened during July 6-10.
-
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on M&A, IPO and Others
PharmaSources/Caicai
July 08, 2020
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
-
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on Policies
PharmaSources/Caicai
July 08, 2020
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
-
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on R&D
PharmaSources/Caicai
July 08, 2020
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
-
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on Approvals
PharmaSources/Caicai
July 08, 2020
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
-
Overseas Marketing of Fruquintinib Accelerated as It Receives the FDA’s Fast Track Designation
PharmaSources/Xiaoyaowan
July 06, 2020
Hutchison MediPharma’s targeted anticancer drug: fruquintinib has recently received the Fast Track designation granted by the FDA for the treatment of patients with metastatic colorectal cancer (mCRC).
-
The Second CAR-T Therapy in China Applied for Marketing
PharmaSources/Dopine
July 01, 2020
On June 30, according to the official website of CDE, the marketing application of a CAR-T therapy, JWCAR029 by JW Therapeutics was accepted by CDE.
-
Novartis' Global Innovative siRNA Long-Acting Lipid-lowering Therapy Submitted Clinical Application in China
PharmaSources/Xiaoyaowan
July 01, 2020
On June 28, the CDE official website showed that Novartis' siRNA long-acting lipid-lowering drug Inclisiran submitted a clinical application in China and has been accepted and accepted.
-
Pharmaceutical News of the Week (June.22-27) | PharmaSources.com
PharmaSources/Caicai
July 01, 2020
With the last week of June coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 22-28, including 22 pieces.
-
The Layout of Inhalation Formulations in the Chinese Market (II)
PharmaSources/Zhulikou431
June 24, 2020
As the inhalation formulation market is developing in China, the Chinese government has gradually introduced favorable policies to offer support.